90 related articles for article (PubMed ID: 8396082)
21. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
Hoepelman AI; Sips AP; van Helmond JL; van Barneveld PW; Neve AJ; Zwinkels M; Rozenberg-Arska M; Verhoef J
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():147-52. PubMed ID: 8396086
[TBL] [Abstract][Full Text] [Related]
22. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias.
Schönwald S; Gunjaca M; Kolacny-Babić L; Car V; Gosev M
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():123-6. PubMed ID: 2154431
[TBL] [Abstract][Full Text] [Related]
23. Single dose azithromycin for the treatment of uncomplicated otitis media.
Arguedas A; Loaiza C; Soley C
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S108-14. PubMed ID: 14770073
[TBL] [Abstract][Full Text] [Related]
24. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
25. Azithromycin in upper respiratory tract infections: a clinical trial in children with otitis media.
Pestalozza G; Cioce C; Facchini M
Scand J Infect Dis Suppl; 1992; 83():22-5. PubMed ID: 1336892
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia.
Myburgh J; Nagel GJ; Petschel E
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():163-9. PubMed ID: 8396088
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin for acute lower respiratory tract infections.
Panpanich R; Lerttrakarnnon P; Laopaiboon M
Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
[TBL] [Abstract][Full Text] [Related]
28. Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications.
Drew RH; Gallis HA
Pharmacotherapy; 1992; 12(3):161-73. PubMed ID: 1319048
[TBL] [Abstract][Full Text] [Related]
29. Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update.
Ruuskanen O
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S135-9. PubMed ID: 14770077
[TBL] [Abstract][Full Text] [Related]
30. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
Bradbury F
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
[TBL] [Abstract][Full Text] [Related]
31. Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species.
Lassus A
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():115-21. PubMed ID: 2154430
[TBL] [Abstract][Full Text] [Related]
32. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials.
Pitsouni E; Iavazzo C; Athanasiou S; Falagas ME
Int J Antimicrob Agents; 2007 Sep; 30(3):213-21. PubMed ID: 17596917
[TBL] [Abstract][Full Text] [Related]
33. An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. The Paediatric Azithromycin Study Group.
Lauvau DV; Verbist L
J Int Med Res; 1997; 25(5):285-95. PubMed ID: 9364291
[TBL] [Abstract][Full Text] [Related]
34. Azithromycin in lower respiratory tract infections.
Lode H; Schaberg T
Scand J Infect Dis Suppl; 1992; 83():26-33. PubMed ID: 1336893
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
Montero L
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():125-31. PubMed ID: 8818853
[TBL] [Abstract][Full Text] [Related]
36. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
[TBL] [Abstract][Full Text] [Related]
37. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
Peters DH; Friedel HA; McTavish D
Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
[TBL] [Abstract][Full Text] [Related]
38. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
[TBL] [Abstract][Full Text] [Related]
39. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group.
Martin DH; Mroczkowski TF; Dalu ZA; McCarty J; Jones RB; Hopkins SJ; Johnson RB
N Engl J Med; 1992 Sep; 327(13):921-5. PubMed ID: 1325036
[TBL] [Abstract][Full Text] [Related]
40. [The clinical and economic efficacies of short courses of azithromycin in acute sinusitis].
Karpov OI
Antibiot Khimioter; 1999; 44(10):28-32. PubMed ID: 10635419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
